Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice

Authors :: Pauwels, R.W.M. (Renske Wilhelmina Maria)
Vries, A.C. (Annemarie) de
van der Woude, C.J. (Christien Janneke)
Pauwels, R.W.M. (Renske Wilhelmina Maria)
Vries, A.C. (Annemarie) de
van der Woude, C.J. (Christien Janneke)
Publication Year :: 2020
Abstract: Background and Aim: The association of fecal calprotectin (FC) and endoscopic response in inflammatory bowel disease patients during vedolizumab (VDZ) treatment is largely unknown. The aim of this study is to assess the diagnostic value of FC to predict endoscopic respon

Database :: OAIster
Notes :: application/pdf, Journal of Gastroenterology and Hepatology, English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1157012110
Document Type :: Electronic Resource
Full Text :: https://doi.org/10.1111.jgh.15063

Full Text Access

Tools